Merck (MRK) Income from Non-Controlling Interests (2009 - 2026)

Merck (MRK) has reported Income from Non-Controlling Interests for 18 consecutive years, with -$3.0 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Income from Non-Controlling Interests fell 150.0% year-over-year to -$3.0 million; the TTM figure through Mar 2026 stood at -$1.0 million (down 105.88% YoY), while the FY2025 annual figure was $9.0 million, down 43.75% from the prior year.
• Income from Non-Controlling Interests fell to -$3.0 million in Q1 2026 per MRK's latest filing, from -$1.0 million in the prior quarter.
• Across five years, Income from Non-Controlling Interests topped out at $6.0 million in Q2 2024 and bottomed at -$3.0 million in Q1 2022.
• Historically, Income from Non-Controlling Interests has averaged $2.6 million across 5 years, with a median of $3.5 million in 2023.
• Annual changes were most pronounced in 2022 — Income from Non-Controlling Interests surged 400.0% — and 2025, when it plunged 200.0%.
• Merck's Income from Non-Controlling Interests stood at $1.0 million in 2022, then soared by 400.0% to $5.0 million in 2023, then tumbled by 80.0% to $1.0 million in 2024, then slumped by 200.0% to -$1.0 million in 2025, then slumped by 200.0% to -$3.0 million in 2026.
• Business Quant data shows MRK's Income from Non-Controlling Interests at -$3.0 million in Q1 2026, -$1.0 million in Q4 2025, and $2.0 million in Q3 2025.